[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Candover and Cinven & springer
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: RE: Candover and Cinven & springer
- From: Howard Stanbury <H.STANBURY@IFIS.ORG>
- Date: Mon, 3 Feb 2003 08:11:25 EST
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
[NB from the Moderator: Thanks to all for this information from the Times article. At this point, having forwarded 3 such messages, we'll stop forwarding should there be any more -- but your quick resonses are all much appreciated.] I'll paraphrase the article for you: The joint bid is confirmed from Candover and Cinven at GBP 650m. They are at the front of the queue to buy the business because trade buyers such as Elsevier have decided not to join the auction. The sale is expected to be arranged in March. A source is quoted as saying: "We no longer expect any of the big players in the market such as Wolters Kluwer or Thomson Corporation to make a move. And the offer from Cinven and Candover is strong." Bertelsman is selling because it wants to re-focus on television and music interests; C&C are attracted because "it has stable subscriptions and scope for price rises. It makes profits of more than �46m. Raising a large bank loan to help finance the deal would be made easier by this secure cashflow." The rest of the short report reviews the purchase by C&C of Kluwer Academic and the events that forced Bertelsman to sell. --
- Prev by Date: RE: Candover and Cinven & springer
- Next by Date: SPARC Partners with Neuro-Oncology
- Prev by thread: RE: Candover and Cinven & springer
- Next by thread: 900 million euros offered for Springer
- Index(es):